Molecular diagnosis and management of viral infections in hematopoietic stem cell transplant recipients (Q38002109)

26 August 2017

title

Molecular diagnosis and management of viral infections in hematopoietic stem cell transplant recipients (English)

1 reference

stem cell transplantation

26 August 2017

main subject

1 reference

Sabine Breuer

1

1 reference

26 August 2017

Margit Rauch

series ordinal

2

1 reference

26 August 2017

Susanne Matthes-Martin

series ordinal

3

1 reference

26 August 2017

Thomas Lion

series ordinal

4

1 reference

26 August 2017

publication date

1 April 2012

1 reference

Molecular Diagnosis and Therapy

26 August 2017

published in

1 reference

26 August 2017

volume

16

1 reference

26 August 2017

issue

2

1 reference

26 August 2017

page(s)

63-77

1 reference

https://scigraph.springernature.com/pub.10.1007/bf03256431

26 August 2017

exact match

0 references

cites work

Umbilical cord blood transplantation: basic biology and clinical challenges to immune reconstitution

1 reference

https://api.crossref.org/works/10.1007%2FBF03256431

The great debate: haploidentical or cord blood transplant

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256431

Unmanipulated HLA-mismatched/haploidentical blood and marrow hematopoietic stem cell transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256431

Cytomegalovirus infection/disease after hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256431

Adenovirus infections in stem cell transplant recipients: recent developments in understanding of pathogenesis, diagnosis and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256431

Role of cell culture for virus detection in the age of technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256431

Real-time quantitative PCR assays for detection and monitoring of pathogenic human viruses in immunosuppressed pediatric patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256431

Molecular detection and quantitative analysis of the entire spectrum of human adenoviruses by a two-reaction real-time PCR assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256431

Clinical virology in real time

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256431

Typing of human adenoviruses in specimens from immunosuppressed patients by PCR-fragment length analysis and real-time quantitative PCR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256431

Cytomegalovirus quantification: where to next in optimising patient management?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256431

Monitoring of cytomegalovirus reactivation in bone marrow transplant recipients by real-time PCR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256431

Comparison of commercial and in-house Real-time PCR assays for quantification of Epstein-Barr virus (EBV) DNA in plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256431

Molecular monitoring of adenovirus in peripheral blood after allogeneic bone marrow transplantation permits early diagnosis of disseminated disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256431

Monitoring of adenovirus load in stool by real-time PCR permits early detection of impending invasive infection in patients after allogeneic stem cell transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256431

PCR diagnostics and monitoring of adenoviral infections in hematopoietic stem cell transplantation recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256431

Improved outcome for children with disseminated adenoviral infection following allogeneic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256431

Opportunistic virus DNA levels after pediatric stem cell transplantation: serostatus matching, anti-thymocyte globulin, and total body irradiation are additive risk factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256431

Adenovirus infection rates in pediatric recipients of alternate donor allogeneic bone marrow transplants receiving either antithymocyte globulin (ATG) or alemtuzumab (Campath).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256431

Improved outcome from invasive adenovirus infection in pediatric patients after hemopoietic stem cell transplantation using intensive clinical surveillance and early intervention.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256431

Observational prospective study of viral infections in children undergoing allogeneic hematopoietic cell transplantation: a 3-year GETMON experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256431

Cidofovir for the treatment of adenoviral infection in pediatric hematopoietic stem cell transplant patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256431

Outcome and clinical course of 100 patients with adenovirus infection following bone marrow transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256431

Incidence and outcome of adenovirus disease in transplant recipients after reduced-intensity conditioning with alemtuzumab

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256431

Clinical and in vitro evaluation of cidofovir for treatment of adenovirus infection in pediatric hematopoietic stem cell transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256431

Using the whole-genome sequence to characterize and name human adenoviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256431

How we treat cytomegalovirus in hematopoietic cell transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256431

Safe adoptive transfer of virus-specific T-cell immunity for the treatment of systemic adenovirus infection after allogeneic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256431

Antiadenovirus activities of several classes of nucleoside and nucleotide analogues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256431

Assessment of disseminated adenovirus infections using quantitative plasma PCR in adult allogeneic stem cell transplant recipients receiving reduced intensity or myeloablative conditioning.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256431

Targeted monitoring of patients at high risk of post-transplant lymphoproliferative disease by quantitative Epstein-Barr virus polymerase chain reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256431

High-risk adenovirus-infected pediatric allogeneic hematopoietic progenitor cell transplant recipients and preemptive cidofovir therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256431

Safety and tolerability of cidofovir in high-risk pediatric patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256431

Donor CMV serologic status and outcome of CMV-seropositive recipients after unrelated donor stem cell transplantation: an EBMT megafile analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256431

Comparative sequence analysis of the hexon gene in the entire spectrum of human adenovirus serotypes: phylogenetic, taxonomic, and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256431

How I treat adenovirus in hematopoietic stem cell transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256431

Treatment of adenovirus-associated haemorrhagic cystitis with ganciclovir.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256431

Intravenous ribavirin treatment for severe adenovirus disease in immunocompromised children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256431

Effect of ribavirin on the plasma viral DNA load in patients with disseminating adenovirus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256431

Management of CMV, HHV-6, HHV-7 and Kaposi-sarcoma herpesvirus (HHV-8) infections in patients with hematological malignancies and after SCT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256431

Clinical uses of cidofovir

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256431

CMX001 potentiates the efficacy of acyclovir in herpes simplex virus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256431

Eradication of disseminated adenovirus infection in a pediatric hematopoietic stem cell transplantation recipient using the novel antiviral agent CMX001.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256431

Adenoviral infections and a prospective trial of cidofovir in pediatric hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256431

Treatment of adenovirus infections in patients undergoing allogeneic hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256431

Cidofovir for adenovirus infections after allogeneic hematopoietic stem cell transplantation: a survey by the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256431

Cidofovir for treating adenoviral hemorrhagic cystitis in hematopoietic stem cell transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256431

A rapid quantitative PCR-based assay for testing antiviral agents against human adenoviruses demonstrates type specific differences in ribavirin activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256431

Reconstitution of adenovirus-specific cell-mediated immunity in pediatric patients after hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256431

Combined CD8+ and CD4+ adenovirus hexon-specific T cells associated with viral clearance after stem cell transplantation as treatment for adenovirus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256431

Simultaneous isolation of CD8(+) and CD4(+) T cells specific for multiple viruses for broad antiviral immune reconstitution after allogeneic stem cell transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256431

Cytotoxic T lymphocyte therapy with donor T cells prevents and treats adenovirus and Epstein-Barr virus infections after haploidentical and matched unrelated stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256431

Monoculture-derived T lymphocytes specific for multiple viruses expand and produce clinically relevant effects in immunocompromised individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256431

Prevention and management of CMV-related problems after hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256431

Pre-emptive treatment of CMV DNAemia in paediatric stem cell transplantation: the impact of recipient and donor CMV serostatus on the incidence of CMV disease and CMV-related mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256431

The impact of cytomegalovirus serostatus of donor and recipient before hematopoietic stem cell transplantation in the era of antiviral prophylaxis and preemptive therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256431

Cytomegalovirus reactivation in pediatric hemopoietic progenitors transplant: a retrospective study on the risk factors and the efficacy of treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256431

Randomized comparison of oral valacyclovir and intravenous ganciclovir for prevention of cytomegalovirus disease after allogeneic bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256431

Maribavir prophylaxis for prevention of cytomegalovirus infection in allogeneic stem cell transplant recipients: a multicenter, randomized, double-blind, placebo-controlled, dose-ranging study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256431

Maribavir prophylaxis for prevention of cytomegalovirus disease in recipients of allogeneic stem-cell transplants: a phase 3, double-blind, placebo-controlled, randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256431

Oral valganciclovir leads to higher exposure to ganciclovir than intravenous ganciclovir in patients following allogeneic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256431

Randomized multicenter trial of foscarnet versus ganciclovir for preemptive therapy of cytomegalovirus infection after allogeneic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256431

Cidofovir for cytomegalovirus infection and disease in allogeneic stem cell transplant recipients. The Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256431

Cidofovir for cytomegalovirus reactivation in pediatric patients after hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256431

A randomized, controlled trial comparing ganciclovir to ganciclovir plus foscarnet (each at half dose) for preemptive therapy of cytomegalovirus infection in transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256431

Use of foscarnet for cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation from a related donor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256431

Adoptive T cell immunotherapy for cytomegalovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256431

Adoptive cellular therapy for early cytomegalovirus infection after allogeneic stem-cell transplantation with virus-specific T-cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256431

Adoptive transfer of pp65-specific T cells for the treatment of chemorefractory cytomegalovirus disease or reactivation after haploidentical and matched unrelated stem cell transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256431

CD4+ T cells are required for the maintenance, not programming, of memory CD8+ T cells after acute infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256431

Outcome of treatment of Epstein-Barr virus-related post-transplant lymphoproliferative disorder in hematopoietic stem cell recipients: a comprehensive review of reported cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256431

EBV reactivation and post transplant lymphoproliferative disorders following allogeneic SCT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256431

Epstein-barr virus-infected resting memory B cells, not proliferating lymphoblasts, accumulate in the peripheral blood of immunosuppressed patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256431

Management of HSV, VZV and EBV infections in patients with hematological malignancies and after SCT: guidelines from the Second European Conference on Infections in Leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256431

Post-transplant lymphoproliferative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256431

How I treat EBV lymphoproliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256431

Evaluation of use of Epstein-Barr viral load in patients after allogeneic stem cell transplantation to diagnose and monitor posttransplant lymphoproliferative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256431

Preemptive diagnosis and treatment of Epstein-Barr virus-associated post transplant lymphoproliferative disorder after hematopoietic stem cell transplant: an approach in development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256431

Rituximab treatment for Epstein-Barr virus DNAemia after alternative-donor hematopoietic stem cell transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256431

Incidence and dynamics of Epstein-Barr virus reactivation after alemtuzumab-based conditioning for allogeneic hematopoietic stem-cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256431

Pre-emptive rituximab based on viraemia and T cell reconstitution: a highly effective strategy for the prevention of Epstein-Barr virus-associated lymphoproliferative disease following stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256431

Biology and adoptive cell therapy of Epstein-Barr virus-associated lymphoproliferative disorders in recipients of marrow allografts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256431

Cellular responses to viral infection in humans: lessons from Epstein-Barr virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256431

Long-term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of gene-modified virus-specific T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256431

Allogeneic cytotoxic T-cell therapy for EBV-positive posttransplantation lymphoproliferative disease: results of a phase 2 multicenter clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256431

Effective and long-term control of EBV PTLD after transfer of peptide-selected T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256431

Salvage chemotherapy for refractory and relapsed posttransplant lymphoproliferative disorders (PTLD) after treatment with single-agent rituximab.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256431

Update on human herpesvirus 6 biology, clinical features, and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256431

Emerging viruses in transplantation: there is more to infection after transplant than CMV and EBV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256431

Clinical outcomes of human herpesvirus 6 reactivation after hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256431

Human herpesvirus 6 DNA in plasma after allogeneic stem cell transplantation: incidence and clinical significance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256431

Risk factors for developing human herpesvirus 6 (HHV-6) reactivation after allogeneic hematopoietic stem cell transplantation and its association with central nervous system disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256431

Impact of human herpesvirus-6 after haematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256431

Post-transplant acute limbic encephalitis: clinical features and relationship to HHV6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256431

HHV-6 reactivation and its effect on delirium and cognitive functioning in hematopoietic cell transplantation recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256431

Prospective, comprehensive, and effective viral monitoring in children undergoing allogeneic hematopoietic stem cell transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256431

Human herpesvirus 6 infection after hematopoietic cell transplantation: is routine surveillance necessary?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256431

Herpesviruses and chromosomal integration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256431

Herpesvirus telomeric repeats facilitate genomic integration into host telomeres and mobilization of viral DNA during reactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256431

Chromosomal integration of human herpesvirus 6 is the major mode of congenital human herpesvirus 6 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256431

Human herpesvirus 6 DNA levels in cerebrospinal fluid due to primary infection differ from those due to chromosomal viral integration and have implications for diagnosis of encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256431

Diagnostic assays for active infection with human herpesvirus 6 (HHV-6).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256431

Human herpesvirus 6 in hematological malignancies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256431

Ganciclovir is effective for prophylaxis and treatment of human herpesvirus-6 in allogeneic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256431

Antiviral prophylaxis may prevent human herpesvirus-6 reactivation in bone marrow transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256431

Plasma HHV-6 viral load-guided preemptive therapy against HHV-6 encephalopathy after allogeneic stem cell transplantation: a prospective evaluation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256431

Preemptive therapy of human herpesvirus-6 encephalitis with foscarnet sodium for high-risk patients after hematopoietic SCT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256431

Human herpesvirus 6 and central nervous system disease in hematopoietic cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256431

Human herpesvirus-6 infection in solid organ and stem cell transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256431

Infection with Herpes Simplex Virus and Cell-Mediated Immunity after Marrow Transplant

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256431

Resistance to antiviral drugs in herpes simplex virus infections among allogeneic stem cell transplant recipients: risk factors and prognostic significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256431

Resistant herpes simplex virus type 1 infection: an emerging concern after allogeneic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256431

Treatment of an acyclovir and foscarnet-resistant herpes simplex virus infection with cidofovir in a child after an unrelated bone marrow transplant

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256431

Successful treatment of foscarnet-resistant herpes simplex stomatitis with intravenous cidofovir in a child

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256431

Inappropriate antidiuretic hormone secretion, abdominal pain and disseminated varicella-zoster virus infection: an unusual triad in a patient 6 months post mini-allogeneic peripheral stem cell transplant for chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256431

Inappropriate antidiuretic hormone secretion, abdominal pain and disseminated varicella-zoster virus infection: an unusual and fatal triad in a patient 13 months post Rituximab and autologous stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256431

Disseminated zoster, hyponatraemia, severe abdominal pain and leukaemia relapse: recognition of a new clinical quartet after bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256431

Severe abdominal pain and inappropriate antidiuretic hormone secretion preceding varicella-zoster virus reactivation 10 months after autologous stem cell transplantation for acute myeloid leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256431

Triad of severe abdominal pain, inappropriate antidiuretic hormone secretion, and disseminated varicella-zoster virus infection preceding cutaneous manifestations after hematopoietic stem cell transplantation: utility of PCR for early recognition an

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256431

Clinical relevance of quantitative varicella-zoster virus (VZV) DNA detection in plasma after stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256431

Effect of oral acyclovir against primary and secondary viraemia in incubation period of varicella

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256431

Postexposure prophylaxis against varicella-zoster virus infection among recipients of hematopoietic stem cell transplant: unresolved issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256431

Foscarnet salvage therapy for acyclovir-resistant varicella zoster: report of a novel thymidine kinase mutation and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256431

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256431

Bk virus: a clinical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256431

Polyomavirus BK infection in blood and marrow transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256431

BK virus encephalitis with thrombotic microangiopathy in an allogeneic hematopoietic stem cell transplant recipient

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256431

BK virus nephropathy in a pediatric autologous stem-cell transplant recipient

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256431

BK DNA viral load in plasma: evidence for an association with hemorrhagic cystitis in allogeneic hematopoietic cell transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256431

BK virus infection is associated with hematuria and renal impairment in recipients of allogeneic hematopoetic stem cell transplants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256431

Antivirals for the treatment of polyomavirus BK replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256431

Ciprofloxacin decreased polyoma BK virus load in patients who underwent allogeneic hematopoietic stem cell transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256431

Anti-BK virus activity of ciprofloxacin and related antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256431

Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256431

Low-dose cidofovir in the treatment of symptomatic BK virus infection in patients undergoing allogeneic hematopoietic stem cell transplantation: a retrospective analysis of an algorithmic approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256431

Cidofovir for BK virus-associated hemorrhagic cystitis: a retrospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256431

Interlaboratory comparison of cytomegalovirus viral load assays.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256431

Interlaboratory comparison of epstein-barr virus viral load assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256431

Description of an adenovirus A31 outbreak in a paediatric haematology unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256431

Application of viral-load kinetics to identify patients who develop cytomegalovirus disease after transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256431

Preemptive Therapy of EBV-Related Lymphoproliferative Disease after Pediatric Haploidentical Stem Cell Transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256431

CMV pneumonia in allogeneic BMT recipients undergoing early treatment or pre-emptive ganciclovir therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256431

Invasive adenoviral infections in T-cell-depleted allogeneic hematopoietic stem cell transplantation: high mortality in the era of cidofovir

21 January 2018

1 reference

12 December 2020

Importance of chromosomally integrated HHV-6A and -6B in the diagnosis of active HHV-6 infection

1 reference

12 December 2020

Adenovirus infection after pediatric bone marrow transplantation: is treatment always necessary?

1 reference

12 December 2020

Cidofovir and foscarnet for treatment of human herpesvirus 6 encephalitis in a neutropenic stem cell transplant recipient

1 reference

12 December 2020

Epstein-Barr virus-associated post-transplant lymphoproliferative disorder.

1 reference

12 December 2020

Nucleic acid amplification and related techniques in microbiological diagnostics and epidemiology

1 reference

12 December 2020

Detection of adenovirus-specific T cells in children with adenovirus infection after allogeneic stem cell transplantation

1 reference

12 December 2020

Quantitative and qualitative CD4 T cell immune responses related to adenovirus DNAemia in hematopoietic stem cell transplantation

1 reference

12 December 2020

Effect of oral probenecid coadministration on the chronic toxicity and pharmacokinetics of intravenous cidofovir in cynomolgus monkeys.

1 reference

12 December 2020

Differential susceptibility of adenovirus clinical isolates to cidofovir and ribavirin is not related to species alone.

1 reference

12 December 2020

Inheritance of chromosomally integrated human herpesvirus 6 DNA

1 reference

12 December 2020

Safety and efficacy of CMX001 as salvage therapy for severe adenovirus infections in immunocompromised patients

1 reference

12 December 2020

Late cytomegalovirus disease and mortality in recipients of allogeneic hematopoietic stem cell transplants: importance of viral load and T-cell immunity

1 reference

12 December 2020

Management of CMV infection and disease in transplant patients. 27-29 February 2004.

1 reference

12 December 2020

Risk of lymphoproliferative disorders after bone marrow transplantation: a multi-institutional study

1 reference

12 December 2020

Adenovirus infections following allogeneic stem cell transplantation: incidence and outcome in relation to graft manipulation, immunosuppression, and immune recovery

1 reference

12 December 2020

Donor T cells to treat EBV-associated lymphoma

1 reference

12 December 2020

The genetic basis of human cytomegalovirus resistance and current trends in antiviral resistance analysis

1 reference

12 December 2020

Immune reconstitution and clearance of human adenovirus viremia in pediatric stem-cell recipients

1 reference

12 December 2020

Inappropriate antidiuretic hormone secretion (SIADH) preceding skin manifestations of disseminated varicella zoster virus infection post-BMT.

1 reference

12 December 2020

Oral acyclovir prophylaxis of varicella after intimate contact

1 reference

12 December 2020

Viral-load and B-lymphocyte monitoring of EBV reactivation after allogeneic hemopoietic SCT in children

1 reference

12 December 2020

Chromosomally integrated human herpesvirus 6: questions and answers

1 reference

12 December 2020

Respiratory viral infections in transplant recipients

1 reference

12 December 2020

Varicella-zoster virus infection after marrow transplantation for aplastic anemia or leukemia

1 reference

12 December 2020

Immune reconstitution after double umbilical cord blood stem cell transplantation: comparison with unrelated peripheral blood stem cell transplantation

1 reference

12 December 2020

Molecular diagnosis of visceral herpes zoster

1 reference

12 December 2020

Adenoviral infection after allogeneic stem cell transplantation (SCT): report on 130 patients from a single SCT unit involved in a prospective multi center surveillance study

1 reference

12 December 2020

Neutropenia in allogeneic marrow transplant recipients receiving ganciclovir for prevention of cytomegalovirus disease: risk factors and outcome

1 reference

12 December 2020

Management of cytomegalovirus infection

1 reference

12 December 2020

Infusion of cytotoxic T cells for the prevention and treatment of Epstein-Barr virus-induced lymphoma in allogeneic transplant recipients.

1 reference

12 December 2020

Risk factors for the development of cytomegalovirus disease after allogeneic stem cell transplantation

1 reference

12 December 2020

Prompt versus preemptive intervention for EBV lymphoproliferative disease

1 reference

12 December 2020

Treatment with ganciclovir of adenovirus pneumonia in a cardiac transplant patient

1 reference

12 December 2020

Cytomegalovirus excretion as a predictor of cytomegalovirus disease after marrow transplantation: importance of cytomegalovirus viremia

1 reference

12 December 2020

Disseminated adenovirus infections after allogeneic hematopoietic stem cell transplantation: incidence, risk factors and outcome

1 reference

12 December 2020

Contemporary management of cytomegalovirus infection in transplant recipients: guidelines from an IHMF workshop, 2007.

1 reference

12 December 2020

Adenovirus infection in paediatric stem cell transplant recipients: increased risk in young children with a delayed immune recovery

1 reference

12 December 2020

The role of HLA mismatch, splenectomy and recipient Epstein-Barr virus seronegativity as risk factors in post-transplant lymphoproliferative disorder following allogeneic hematopoietic stem cell transplantation.

1 reference

12 December 2020

In vitro susceptibility of adenovirus to antiviral drugs is species-dependent.

1 reference

12 December 2020

Cytomegalovirus in hematopoietic stem cell transplant recipients

1 reference

12 December 2020

Postexposure prophylaxis of varicella in family contact by oral acyclovir.

1 reference

12 December 2020

The challenge of respiratory virus infections in hematopoietic cell transplant recipients

1 reference

12 December 2020

Increasing incidence of adenovirus disease in bone marrow transplant recipients

1 reference

12 December 2020

Visceral varicella zoster infection after bone marrow transplantation without skin involvement and the use of PCR for diagnosis

1 reference

12 December 2020

Epstein Barr viral load monitoring by quantitative PCR in renal transplant patients

1 reference

12 December 2020

The clinicopathologic spectrum of posttransplantation lymphoproliferative disorders

1 reference

12 December 2020

Full myeloablative conditioning and an unrelated HLA mismatched donor increase the risk for BK virus-positive hemorrhagic cystitis in allogeneic hematopoetic stem cell transplanted patients.

1 reference

12 December 2020

Dendritic cell vaccination in allogeneic stem cell recipients: induction of human cytomegalovirus (HCMV)-specific cytotoxic T lymphocyte responses even in patients receiving a transplant from an HCMV-seronegative donor

1 reference

12 December 2020

Human herpesvirus type 6 and human herpesvirus type 7 infections of the central nervous system.

1 reference

12 December 2020

Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor

1 reference

12 December 2020

Risk factors associated with late cytomegalovirus reactivation after allogeneic stem cell transplantation for hematological malignancies

1 reference

12 December 2020

Active CMV disease does not always correlate with viral load detection

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF03256431

1 reference

Dimensions Publication ID

26 August 2017

1029582545

0 references

1 reference